Transcenta Holding Limited (6628.HK)

HKD 0.6

(0.0%)

Revenue Summary of Transcenta Holding Limited

Transcenta Holding Limited's latest annual revenue in 2023 was 53.84 Million CNY , down -47.15% from previous year.
Transcenta Holding Limited's latest quarterly revenue in 2024 Q2 was 2.28 Million CNY , down 0.0% from previous quarter.
Transcenta Holding Limited reported a annual revenue of 101.89 Million CNY in annual revenue 2022, up 102.8% from previous year.
Transcenta Holding Limited reported a annual revenue of 50.24 Million CNY in annual revenue 2021, down -37.96% from previous year.
Transcenta Holding Limited reported a quarterly revenue of 2.28 Million CNY for 2024 Q2, down 0.0% from previous quarter.
Transcenta Holding Limited reported a quarterly revenue of 18.04 Million CNY for 2023 Q1, down -54.97% from previous quarter.

Annual Revenue Chart of Transcenta Holding Limited (2023 - 2019)

Historical Annual Revenue of Transcenta Holding Limited (2023 - 2019)

Year	Revenue	Revenue Growth
2023	53.84 Million CNY	-47.15%
2022	101.89 Million CNY	102.8%
2021	50.24 Million CNY	-37.96%
2020	80.98 Million CNY	83.46%
2019	44.14 Million CNY	0.0%

Year	Revenue	Revenue Growth
2024 Q1	2.28 Million CNY	-74.31%
2024 Q2	2.28 Million CNY	0.0%
2023 Q1	18.04 Million CNY	-54.97%
2023 FY	53.84 Million CNY	-47.15%
2023 Q4	8.88 Million CNY	0.0%
2023 Q3	8.88 Million HKD	-50.77%
2023 Q2	18.04 Million CNY	0.0%
2022 Q2	10.87 Million CNY	0.0%
2022 Q1	10.87 Million CNY	-7.64%
2022 FY	101.89 Million CNY	102.8%
2022 Q4	40.06 Million CNY	0.0%
2022 Q3	40.06 Million CNY	268.3%
2021 Q3	11.77 Million CNY	-37.36%
2021 Q4	11.77 Million CNY	0.0%
2021 Q2	18.8 Million CNY	138.51%
2021 Q1	7.88 Million CNY	-70.07%
2021 FY	50.24 Million CNY	-37.96%
2020 Q1	6.81 Million CNY	0.0%
2020 FY	80.98 Million CNY	83.46%
2020 Q4	26.33 Million CNY	0.0%
2020 Q3	26.33 Million CNY	22.5%
2020 Q2	21.49 Million CNY	215.7%
2019 FY	44.14 Million CNY	0.0%

Peer Revenue Comparison of Transcenta Holding Limited

Name	Revenue	Revenue Difference
Uni-Bio Science Group Limited	484.71 Million HKD	88.891%
CK Life Sciences Int'l., (Holdings) Inc.	5.32 Billion HKD	98.988%